Doctor Innovates Cell Therapy in India; Seeks to Make Vision Restoration 80% Cheaper

Eyestem, a leading cell therapy venture in India, developed its flagship product, 'Eyecyte-RPE' which costs less than treatment in the West.

Related Keywords

India ,Ahmedabad ,Gujarat ,Japan ,United States ,Oregon ,Israel ,Jogin Desai ,Rajani Battu ,Science University ,Eyestem Team ,Oregon Health ,Eyestem Team Image ,For Dr Jogin Desai ,Stem Cell ,Regenerative Medicine ,Age Related Macular Degeneration ,Dry Age Related Macular Degeneration ,Macular Degeneration ,Induced Pluripotent Stem Cell ,Incurable Blindness ,Retinal Pigment Epithelium ,Drugs Controller General ,Retinitis Pigmentosa ,Idiopathic Pulmonary Fibrosis ,Chronic Obstructive Pulmonary Disease ,Cell Therapy ,Endiya Partners ,Kotak Private Equity ,